How HIV Destroys the Immune System: CD4+ T-Cell Depletion
HIV targets CD4+ T-helper cells, the orchestrators of adaptive immunity. Progressive loss leads to acquired immunodeficiency syndrome (AIDS).
Pathogenesis
- Entry: gp120 binds CD4 + coreceptor (CCR5/CXCR4) → fusion.
- Reverse transcription: Viral RNA → DNA (integrase integrates into host genome).
- Replication: Host machinery produces virions → budding → cell death (lysis, apoptosis, immune clearance).
- CD4 decline: ~50–100 cells/μL/year untreated.
Consequences of CD4 Loss
- >500 cells/μL: Near-normal immunity.
- 200–500: Mild immune dysfunction; risk of shingles, thrush, bacterial pneumonia.
- <200: AIDS-defining opportunistic infections (OIs): PCP, toxoplasmosis, MAC, CMV, cryptococcal meningitis.
- Malignancies: Kaposi sarcoma, NHL, cervical/anal cancer (HPV-driven).
- Neurocognitive: HIV-associated neurocognitive disorder (HAND).
Treatment Changes Everything
ART suppresses viral load to undetectable → CD4 recovery → near-normal lifespan, no transmission (U=U). Early initiation is standard.
HIV & AIDS - Related Articles
- Body Cavities in Animals: Enhancing Mobility, Organ Protection, and Evolutionary Success
- HIV and Skin Conditions: Understanding Dermatological Manifestations
- HIV Blood Tests: ELISA and Western Blot Explained
- Exercise and HIV: A Guide to Safe & Effective Workouts
- Understanding HIV/AIDS: Testing, Symptoms & Prevention
- HIV Transmission Myths: Sharing a Glass Does Not Spread HIV
- HIV Transmission and Kissing: No Risk from Saliva Alone
